USA:

Europe:

Email:

Consultation

PE Anti-Human CD279 (PD-1) (J110)

  • Product Information
  • Description
Catalog: C-FC-4798A
Product Type: FCM Antibody
Size: 5 µl(1µg)/test
Reactivity: Human
Positive FC: human peripheral blood lymphocytes
Recommended dilution: This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl(1µg) per 10^6 cells in a 100 µl suspension or 5 µl(1µg) per 100 µl of whole blood.
Analysis mode: FC
Host: Mouse
Isotype: IgG1
Alternate names: CD279, hPD 1, hPD l, PD1, PDCD1, programmed cell death 1, Protein PD 1, SLEB2
Storage: 2-8°C
Purification method: Affinity purification
Immunogen: N/A
Genn_ID: 5133
Gene accession: BC074740
Gene symbol: PDCD1
Buffer: Phosphate based buffer with 0.09% sodium azide and 0.1% gelatin, pH 7.2.

Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436).

Verification Code
top